Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: A meta-analysis

BACKGROUND: Ankylosing spondylitis (AS) is a chronic immune-mediated disease affecting the sacroiliac joints and the spine, manifesting with new bone formation and osteopenia. Five tumor necrosis factor-alpha (TNF-α) inhibitors (infliximab, etanercept, adalimumab, certolizumab, and golimumab) are av...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicine (Baltimore)
Egile Nagusiak: Ma, Zeren, Liu, Xiaoping, Xu, Xiaosheng, Jiang, Jie, Zhou, Jian, Wang, Jia, Chen, Dewang, Luo, Song
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2017
Gaiak:
6900
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5484196/
https://ncbi.nlm.nih.gov/pubmed/28640088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000007145
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak